mTOR signaling is activated by FLT3 kinase and promotes survival of <it>FLT3-</it>mutated acute myeloid leukemia cells
<p>Abstract</p> <p>Activating mutations of the <it>FLT3 </it>gene mediate leukemogenesis, at least in part, through activation of PI3K/AKT. The mammalian target of rapamycin (mTOR)-Raptor signaling pathway is known to act downstream of AKT. Here we show that the mTOR ef...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/292 |